Healthy volunteers help uncover drug interactions for INCB161734
NCT ID NCT07018635
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 17 times
Summary
This study looked at how three common medications—itraconazole, rifampin, and acid reducers—change the way the body handles a drug called INCB161734. Sixty-three healthy adults aged 18 to 55 took part. The goal was to measure drug levels and safety, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea Clinical Research Unit Ltd Labcorp Clinical Research Unit Limited Madison
Madison, Wisconsin, 53704, United States
Conditions
Explore the condition pages connected to this study.